Immune Thrombocytopenia following COVID-19 Vaccine

  • Prasad S
  • Jariwal R
  • Adebayo M
  • et al.
N/ACitations
Citations of this article
22Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Several vaccines have been developed and are being administered against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Common side effects include fever, chills, headache, myalgia, and soreness at the injection site. However, some rare adverse effects have also been reported. We present a case of induced thrombocytopenia presenting with petechiae and mucosal bleeding which developed as an adverse response after first-dose administration of the Moderna COVID-19 vaccine.

Cite

CITATION STYLE

APA

Prasad, S., Jariwal, R., Adebayo, M., Jaka, S., Petersen, G., & Cobos, E. (2022). Immune Thrombocytopenia following COVID-19 Vaccine. Case Reports in Hematology, 2022, 1–3. https://doi.org/10.1155/2022/6013321

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free